Oxidative Stress in Alzheimer Disease: Synergy Between the Butterfield and Markesbery Laboratories

Autor Butterfield, D. Allan
Vydáno 2010

The 2013 Discovery Award from the Society for Free Radical Biology and Medicine: Selected Discoveries from the Butterfield Laboratory of Oxidative Stress and Its Sequelae in Brain...

Autor Butterfield, D. Allan
Vydáno 2014

PHOSPHOPROTEOMICS OF ALZHEIMER DISEASE BRAIN: INSIGHTS INTO ALTERED BRAIN PROTEIN REGULATION OF CRITICAL NEURONAL FUNCTIONS AND THEIR CONTRIBUTIONS TO SUBSEQUENT COGNITIVE LOSS

Autor BUTTERFIELD, D. Allan
Vydáno v Biochim Biophys Acta Mol Basis Dis (2018)

BRAIN LIPID PEROXIDATION AND ALZHEIMER DISEASE: SYNERGY BETWEEN THE BUTTERFIELD AND MATTSON LABORATORIES

Autor BUTTERFIELD, D. ALLAN
Vydáno v Ageing Res Rev (2020)

Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment

Autor Sultana, Rukhsana, Butterfield, D. Allan
Vydáno 2009

Identification of the Oxidative Stress Proteome in the Brain

Autor Sultana, Rukhsana, Butterfield, D. Allan
Vydáno 2010

Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia

Autor Perluigi, Marzia, Butterfield, D. Allan
Vydáno 2012

Methionine-35 of Aβ(1–42): Importance for Oxidative Stress in Alzheimer Disease

Autor Butterfield, D. Allan, Sultana, Rukhsana
Vydáno 2011

Redox Proteomics: A Key Tool for New Insights into Protein Modification with Relevance to Disease

Autor Butterfield, D. Allan, Perluigi, Marzia
Vydáno v Antioxid Redox Signal (2017)

Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by co-treatment of acetyl-L-carnitine and α-lipoic acid against HNE-mediated oxidative s...

Autor Abdul, Hafiz Mohmmad, Butterfield, D. Allan
Vydáno 2006

Elevation of Glutathione as a Therapeutic Strategy in Alzheimer Disease

Autor Pocernich, Chava B., Butterfield, D. Allan
Vydáno 2011

Redox Proteomics

Autor Butterfield, D. Allan, Dalle-Donne, Isabella
Vydáno 2012

Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease

Autor Butterfield, D. Allan, Boyd-Kimball, Debra
Vydáno v J Alzheimers Dis (2018)

Redox Proteomics and Amyloid β-Peptide: Insights into Alzheimer Disease

Autor Butterfield, D. Allan, Boyd-Kimball, Debra
Vydáno v J Neurochem (2018)

Apolipoprotein E and Oxidative Stress in Brain with Relevance to Alzheimer Disease

Autor Butterfield, D. Allan, Mattson, Mark P.
Vydáno v Neurobiol Dis (2020)

Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease

Autor Butterfield, D. Allan, Boyd-Kimball, Debra
Vydáno v Antioxidants (Basel) (2020)

Amyloid β‐Peptide(1‐42) Contributes to the Oxidative Stress and Neurodegeneration Found in Alzheimer Disease Brain

Autor Butterfield, D. Allan, Boyd‐Kimball, Debra
Vydáno v Brain Pathol (2006)

Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis

Autor Sultana, Rukhsana, Perluigi, Marzia, Butterfield, D. Allan
Vydáno 2009

CHOLESTEROL-INDEPENDENT NEUROPROTECTIVE AND NEUROTOXIC ACTIVITES OF STATINS: PRESPECTIVES FOR STATIN USE IN ALZHEIMER DISEASE AND OTHER AGE-RELATED NEURODEGENERATIVE DISORDERS

Autor Butterfield, D. Allan, Barone, Eugenio, Mancuso, Cesare
Vydáno 2011

4-Hydroxy-2-Nonenal, a Reactive Product of Lipid Peroxidation, and Neurodegenerative Diseases: A Toxic Combination Illuminated by Redox Proteomics Studies

Autor Perluigi, Marzia, Coccia, Raffaella, Butterfield, D. Allan
Vydáno 2012